Acadia and Neurocrine both have catalysts for growth; buy any weakness.
Home builders make up the second-largest allocation in my portfolio, behind biotech.
I've learned that emotions have little use at a poker table; they don't in the stock market, either.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.